Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010118474) COMPOUNDS AFFECTING GLYCEMIC INDEX
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/118474 International Application No.: PCT/AU2010/000427
Publication Date: 21.10.2010 International Filing Date: 16.04.2010
IPC:
C07D 311/30 (2006.01) ,A61K 36/899 (2006.01) ,A61P 3/04 (2006.01) ,A61P 3/10 (2006.01) ,A61K 31/352 (2006.01) ,C07D 311/40 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
311
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
02
ortho- or peri-condensed with carbocyclic rings or ring systems
04
Benzo [b] pyrans, not hydrogenated in the carbocyclic ring
22
with oxygen or sulfur atoms directly attached in position 4
26
with aromatic rings attached in position 2 or 3
28
with aromatic rings attached in position 2 only
30
not hydrogenated in the hetero ring, e.g. flavones
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
88
Liliopsida (monocotyledons)
899
Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
04
Anorexiants; Antiobesity agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
335
having oxygen as the only ring hetero atom, e.g. fungichromin
35
having six-membered rings with one oxygen as the only ring hetero atom
352
condensed with carbocyclic rings, e.g. cannabinols, methantheline
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
311
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
02
ortho- or peri-condensed with carbocyclic rings or ring systems
04
Benzo [b] pyrans, not hydrogenated in the carbocyclic ring
22
with oxygen or sulfur atoms directly attached in position 4
26
with aromatic rings attached in position 2 or 3
40
Separation, e.g. from natural material; Purification
Applicants:
PAYN, Dionne Nadine [GB/AU]; AU (UsOnly)
LEACH, David Norman [AU/AU]; AU (UsOnly)
DESEO, Myrna A. [PH/AU]; AU (UsOnly)
MORRIS, Carol Ann [AU/US]; US (UsOnly)
SACRON INNOVATIONS PTY LIMITED [AU/AU]; Level 1, 80 Jephson Street Toowong QLD 4066, AU (AllExceptUS)
Inventors:
PAYN, Dionne Nadine; AU
LEACH, David Norman; AU
DESEO, Myrna A.; AU
MORRIS, Carol Ann; US
Agent:
FISHER ADAMS KELLY; Level 29 12 Creek Street Brisbane, Queensland 4000, AU
Priority Data:
200990164117.04.2009AU
Title (EN) COMPOUNDS AFFECTING GLYCEMIC INDEX
(FR) COMPOSÉS AFFECTANT L'INDICE GLYCÉMIQUE
Abstract:
(EN) Compounds of formula I are disclosed which are useful as glycemic index lowering agents and/or, as α-amylase and/or α-glucosidase inhibitors. Also disclosed are nutritional and/or pharmaceutical compositions and supplements comprising one or more of these compounds. The compounds will be beneficial to patients who require stabilization of their postprandial glucose levels.
(FR) L'invention porte sur des composés de formule I qui sont utiles comme agents d'abaissement d'indice glycémique et/ou comme inhibiteurs d'α-amylase et/ou d'α-glucosidase. L'invention porte également sur des compositions et compléments nutritionnels et/ou pharmaceutiques comprenant un ou plusieurs de ces composés. Les composés bénéficieront aux patients qui nécessitent une stabilisation de leurs glycémies post-prandiales.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)